Article Versions Notes

Margier M, Kuehnemann C, Hulo N, Morales J, Ashok Kumaar PV, Cros C, Cannelle H, Charmetant J, Verdin E, Canault M, et al. Nicotinamide Mononucleotide Administration Prevents Doxorubicin-Induced Cardiotoxicity and Loss in Physical Activity in Mice. Cells. 2023; 12(1):108. https://doi.org/10.3390/cells12010108

Margier, Marielle, Chisaka Kuehnemann, Nicolas Hulo, Jazmin Morales, Prasanna Vadhana Ashok Kumaar, Cecile Cros, Helene Cannelle, Julie Charmetant, Eric Verdin, Matthias Canault, and et al. 2023. "Nicotinamide Mononucleotide Administration Prevents Doxorubicin-Induced Cardiotoxicity and Loss in Physical Activity in Mice" Cells 12, no. 1: 108. https://doi.org/10.3390/cells12010108

Margier, M., Kuehnemann, C., Hulo, N., Morales, J., Ashok Kumaar, P. V., Cros, C., Cannelle, H., Charmetant, J., Verdin, E., Canault, M., & Grozio, A. (2023). Nicotinamide Mononucleotide Administration Prevents Doxorubicin-Induced Cardiotoxicity and Loss in Physical Activity in Mice. Cells, 12(1), 108. https://doi.org/10.3390/cells12010108